Opportunistic Infections Citation List: May 22 - June 4, 2015
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
1. Development of Selective DprE1 Inhibitors: Design, Synthesis, Crystal Structure and Antitubercular Activity of Benzothiazolylpyrimidine-5-Carboxamides. Chikhale, R., S. Menghani, R. Babu, R. Bansode, G. Bhargavi, N. Karodia, M.V. Rajasekharan, A. Paradkar, and P. Khedekar. European Journal of Medicinal Chemistry, 2015. 96: p. 30-46. PMID[25874329].
[PubMed]. OI_0522-060415.
2. Meropenem-Clavulanic acid Has High in Vitro Activity against Multidrug-resistant Mycobacterium tuberculosis. Davies Forsman, L., C.G. Giske, J. Bruchfeld, T. Schon, P. Jureen, and K. Angeby. Antimicrobial Agents and Chemotherapy, 2015. 59(6): p. 3630-3632. PMID[25824227].
[PubMed]. OI_0522-060415.
3. Tetrahydroisoquinolines Affect the Whole-cell Phenotype of Mycobacterium tuberculosis by Inhibiting the ATP-dependent Mure Ligase. Guzman, J.D., T. Pesnot, D.A. Barrera, H.M. Davies, E. McMahon, D. Evangelopoulos, P.N. Mortazavi, T. Munshi, A. Maitra, E.D. Lamming, R. Angell, M.C. Gershater, J.M. Redmond, D. Needham, J.M. Ward, L.E. Cuca, H.C. Hailes, and S. Bhakta. Antimicrobial Agents and Chemotherapy, 2015. 70(6): p. 1691-1703. PMID[25656411].
[PubMed]. OI_0522-060415.
4. Antimycobacterial Activity of Linezolid against Multidrug-resistant and Extensively Drug-resistant Strains of Mycobacterium tuberculosis in Iran. Kazemian, H., M. Haeili, J. Kardan Yamchi, F. Rezaei, S. Gizaw Feyisa, F. Zahednamazi, P. Mohajeri, S. Zaker Bostanabd, A. Hashemi Shahraki, A.A. Imani Fooladi, and M.M. Feizabadi. International Journal of Antimicrobial Agents, 2015. 45(6): p. 668-670. PMID[25795315].
[PubMed]. OI_0522-060415.
5. Antibiotic Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Guizhou Province of China against 13 Antituberculosis Drugs. Li, N., X. Liao, L. Chen, J. Wang, M. Liu, and H. Zhang. Microbial Drug Resistance, 2015. 21(3): p. 292-296. PMID[25599413].
[PubMed]. OI_0522-060415.
6. 2-Substituted 6-(het)aryl-7-deazapurine Ribonucleosides: Synthesis, Inhibition of Adenosine Kinases, and Antimycobacterial Activity. Malnuit, V., L.P. Slavetinska, P. Naus, P. Dzubak, M. Hajduch, J. Stolarikova, J. Snasel, I. Pichova, and M. Hocek. ChemMedChem, 2015. 10(6): p. 1079-1093. PMID[25882678].
[PubMed]. OI_0522-060415.
Citations from the ISI Web of Knowledge Listings for O.I.
7. Synthesis and Anti-tubercular Activity of 6-(4-Chloro/Methyl-phenyl)-4-arylidene-4,5-dihydropyridazin-3(2H)-one Derivatives against Mycobacterium tuberculosis. Asif, M. and A. Singh. Letters in Drug Design & Discovery, 2015. 12(6): p. 500-504. ISI[000354180200009].
[WOS]. OI_0522-060415.
8. Synthesis and Anti-mycobacterial Activity of 2-Chloronicotinaldehydes Based Novel 1H-1,2,3-Triazolylbenzohydrazides. Suman, P., C. Dayakar, K. Rajkumar, B. Yashwanth, P. Yogeeswari, D. Sriram, J.V. Rao, and B.C. Raju. Bioorganic & Medicinal Chemistry Letters, 2015. 25(11): p. 2390-2394. ISI[000354115400025].
[WOS]. OI_0522-060415.